Aligos Therapeutics ALGS
NASDAQ ALGS
$2.10 +0.12 (+6.06%)
At close: Nov 13, 2026 · 4:00 PM EST

Aligos Therapeutics (ALGS) Share-based Compensation (2019 - 2026)

Updated

Aligos Therapeutics (ALGS) reported Share-based Compensation of $1.28 million for Q3 2026, down 12.6% from $1.47 million a year earlier but up 849.6% from the prior quarter.

Analysis

Aligos Therapeutics (ALGS) Share-based Compensation (2019 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, Aligos Therapeutics' Share-based Compensation came in at $2.96 million, down 11.0% year-over-year; for FY2025, it was $5.04 million, down 40.3% from FY2024.

  • Share-based Compensation has declined for three consecutive years, though with a five-year compound annual growth rate of 11.1% (FY2020 to FY2025).
  • By year, Share-based Compensation came in at $8.45 million in FY2024 (-33.2%), $12.65 million in FY2023 (-13.9%), $14.69 million in FY2022 (+9.2%) and $13.46 million in FY2021 (+352.3%).
  • Five-year quarterly Share-based Compensation spans a low of $50,000 in Q1 2025 and a high of $3.99 million in Q2 2022.
  • Year over year, Share-based Compensation gained in two of the last eight quarters, with an average decline of 9.4%.
  • The high point for year-over-year Share-based Compensation in five years was Q4 2021 (growth of 180.6%); the low point was Q1 2024 (a decline of 96.0%).
  • Per Business Quant data, the three quarters before Q3 2026 came in at $135,000 (Q2 2026), $89,000 (Q1 2026) and $1.46 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 200.00 Mn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 357.00 Mn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 160.00 Mn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 369.00 Mn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 128.00 Mn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 234.00 Mn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 362.00 Mn
10 Aligos Therapeutics 21.97 Mn -314.86 Mn - 1.28 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 1.28 Mn
Jun 30, 2026 135,000.00
Mar 31, 2026 89,000.00
Dec 31, 2025 1.46 Mn
Sep 30, 2025 1.47 Mn
Jun 30, 2025 110,000.00
Mar 31, 2025 50,000.00
Dec 31, 2024 1.71 Mn
Sep 30, 2024 2.04 Mn
Jun 30, 2024 138,000.00
Mar 31, 2024 148,000.00
Dec 31, 2023 2.58 Mn
Sep 30, 2023 3.21 Mn
Jun 30, 2023 3.20 Mn
Mar 31, 2023 3.66 Mn
Dec 31, 2022 3.42 Mn
Sep 30, 2022 3.49 Mn
Jun 30, 2022 3.99 Mn
Mar 31, 2022 3.79 Mn
Dec 31, 2021 3.65 Mn
API Access

Aligos Therapeutics Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ALGS&period=max&api_key=YOUR_API_KEY